AssurX Blog
Straight talk for regulated industries.
FDA’s UDI Initiative Continues to Roll Forward
Jeff Mazik, Vice President, Life Science Solutions, AssurX With the close of the 7th Annual UDI Conference in Baltimore late last month. The FDA took another big step forward in prov [...]
Will New User Fees Fuel More FDA Inspections?
For FY 2016, FDA is requesting $4.9 billion to support our essential functions and priority needs, which is $425 million above the FY 2015 enacted level. Of the total funding, $2.7 bi [...]
FDA Warning Letters Hit Device Makers Over CAPA, MDR Failures
Michael Causey, Editor-in-Chief,Association of Clinical Research Professionals It’s been a little while since we checked the FDA’s outgoing mail tray to find out what inspectors are [...]
Medical Device Makers Express Optimism About Future – But QA Worries About US Regulatory Burden
Crystal may be clear, but crystal balls, at least metaphorically, are certainly not. The late, great political columnist David Broder with The Washington Post used to run a column at t [...]
FDA 510(k) Approval Process Now Averages Over Six Months
If you’ve got six months – and nerves of steel – here’s some good news: You have a 61% percent chance of getting your medical device approved by the FDA. That’s one nugget of interesti [...]
FDA Issues Deadline Reminder to Medical Device Companies on Electronic Medical Device Reporting
Tamar June, VP, Strategic Marketing, AssurX, Inc. Looks like it's crunch time for medical device manufacturers. Whether they submit one or 10,000 medical device reports (MDRs) to the [...]
